RAC 3.79% $1.53 race oncology ltd

Ann: Quarterly Activity Report & Appendix 4C, page-19

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,947 Posts.
    lightbulb Created with Sketch. 1315
    Low volume and a dropping share price off todays quarterly.

    I'm surprised there is no chat from the YOLO'ers on this comment. Surely this should create some hype - basically giving it a 2 month countdown before RAC's own Phase I/II trial commencement...

    https://hotcopper.com.au/data/attachments/3126/3126015-2119f692a27a3c09b979c610bfd682dc.jpg

    Maybe someone needs to highlight it on asx_bets... Or maybe the YOLO'ers have moved on from RAC, or only focused on the other Pillars that have a higher pay out (if successful), even though we're not even at the potential value of Pillar 3 which is pretty much a given.

    In my opinion this is the previous "Naglar 2" trial that was supposed to commence last Nov/Dec, and if you connect all the dots (first comment on synergy of potential combination was a few years ago) I can't see how this trial will fail.

    IMO, DYOR, etc.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.